All In MedTech

Device Trial Radar · NCT06368479

Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

Last checked: Nov 19, 2026Latest source record: Feb 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,400 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,400

Actual

Start

Mar 19, 2024

Primary completion

Jul 19, 2024

Study completion Jul 19, 2024

Sponsor

Lead sponsor
bioLytical LaboratoriesNot on our public-company list
Sponsor type
Industry
First posted
Apr 16, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Screening
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective cross-sectional study in which surgically non-invasive sample-taking is done only for the purpose of testing the samples on iStatis HBsAg Test at the point of care.

Conditions

  • Hepatitis B
  • Hepatitis B Infection

Interventions

  • iStatis HBsAg TestDevice

    Capillary (fingerstick) blood, EDTA venous whole blood, serum and plasma samples to be tested on the iStatis HBsAg Test at the point of care setting.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. iStatis PerformanceTime frame: 3 Months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Epicentre Health Research

    Hillcrest, KwaZulu-Natal, South Africa

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.